TAK-285
CAY-29157-5 5 mg
Data Sheet: 
SDS:
SDS:
CAS
871026-44-7
Formulation
A solid
Purity
≥95%
MW
548
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
TAK-285 is a dual inhibitor of EGFR and HER2 (IC50s = 23 and 17 nM, respectively).{61699} It is selective for EGFR and HER2 over a panel of 36 kinases (IC50s = 250->10,000 nM). TAK-285 inhibits the proliferation of BT474 breast cancer cells (GI50 = 17 nM) as well as induces tumor regression in a 4-1st gastric adenocarcinoma rat xenograft model when administered at doses of 25 and 50 mg/kg.
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
